Abstract:Background & Aims: The therapeutic activity of bone marrow mesenchymal stem cells (MSCs) in a rat model of acute hepatocyte injury through polarizing M2 macrophages, but the molecular pathway of MSCs inducing macrophages M2 polarization in acute hepatocyte injury is unknown. We investigate the molecular pathway of MSCs inducing polarizing M2 macrophages and described the potential therapy of MSC-induced M2 macrophages in acute hepatocyte injury. Methods: Co-culture of Rat hepatic macrophages(M0) and MSCs, the expression levels of M2 polarized markers (CD163, TGF-β, Arg-1) were detected by RT-PCR to confirm the MSC-induced macrophages M2 polarization in vitro. The location of GFP-labeled MSCs and IL-4 was expressed by immunofluorescence. The proteomic profiling to assess the survival and death groups after MSCs transplantation to analysis potential molecular pathway of macrophages M2 polarization. The macrophages M2 polarization marker including IL-4, CD163, TGF-β, IL-10 and Arg1 were detected by Western Blot, RT-PCR and ELISA. The expression levels of ALT and AST were measured in injured hepatocytes supernatant co-cultured with M2 macrophages by ELISA. Results: The expression level of M2 macrophages polarizing markers (CD163, TGF-β, Arg-1) were significantly increased after macrophages co-culture with MSCs in vitro. MSC transplanted into the body are co-expressed with IL-4 by immunofluorescence and liver proteomic analysis identified STAT6 protein involved in the survival and death after MSCs treatment in a rat acute liver failure model. MSC-induced macrophages M2 polarization activated STAT6 protein expression by IL-4. STAT6 inhibitors significantly inhibited the expression of macrophages M2 polarization markers (IL-4, CD163, TGF-β, IL-10 and Arg1). Co-culture of M2 macrophages and injured hepatocytes significantly reduced the secretion of ALT and AST from hepatocytes. Conclusions: MSCs induce macrophages M2 phenotype polarization by activating STAT6, and M2 macrophages increased expression of anti-inflammatory factors(IL-4, CD163, TGF-β, IL-10 and Arg1) and ameliorated acute hepatocyte injury.Funding Statement: This work funded by “Thirteenth Five-Year Plan” Major National Science and technology major projects (2017ZX10201201, 2017ZX10202202); Liaoning Provincial Local Professional Technology Innovation Platform Construction Project (2016007013); Liaoning Provincial Natural Science Foundation 2014021007); Outstanding Scientific Fund of Shengjing Hospital (2011-02).Declaration of Interests: The authors declare that there is no duality of interest associated with this manuscript.Ethics Approval Statement: All procedures involving animals were reviewed and approved by the Institutional Animal Care and Use Committee of the Ethics Committee of Shengjing Hospital of China Medical University Institutional. (IACUC protocol number: 2016PS248K)

Mesenchymal Stem Cells Secreted-Prostaglandin E2 Ameliorates Acute Liver Failure Via Attenuation Cell Death and Regulation of Macrophage Polarization

Mesenchymal stem cell-secreted prostaglandin E2 ameliorates acute liver failure via attenuation of cell death and regulation of macrophage polarization

Correction: Mesenchymal stem cell-secreted prostaglandin E2 ameliorates acute liver failure via attenuation of cell death and regulation of macrophage polarization

Mesenchymal stem cell treatment restores liver macrophages homeostasis to alleviate mouse acute liver injury revealed by single-cell analysis.

Prostaglandin E 2 Secreted by Mesenchymal Stem Cells Protects Against Acute Liver Failure Via Enhancing Hepatocyte Proliferation

Transplantation of Mesenchymal Stem Cells Attenuates Acute Liver Failure in Mice Via an Interleukin-4-dependent Switch to the M2 Macrophage Anti-inflammatory Phenotype

Therapeutic Effect and Mechanism of Mesenchymal Stem Cells on Acute Liver Failure

Mesenchymal Stem Cells Alleviate Acute Liver Failure through Regulating Hepatocyte Apoptosis and Macrophage Polarization

Improvement of mesenchymal stromal cells and their derivatives for treating acute liver failure

Mesenchymal stem cells rescue acute hepatic failure by polarizing M2 macrophages

Mesenchymal Stem Cells Alleviate LPS-induced Acute Lung Injury by Inhibiting the Proinflammatory Function of Ly6C+ CD8+ T Cells

The Effects of Conditioned Medium Derived from Mesenchymal Stem Cells Cocultured with Hepatocytes on Damaged Hepatocytes and Acute Liver Failure in Rats

Interleukin-10 Secreted by Mesenchymal Stem Cells Attenuates Acute Liver Failure Through Inhibiting Pyroptosis

Immunosuppressive Effect Of Mesenchymal Stem Cells On Lung And Gut Cd8(+) T Cells In Lipopolysaccharide-Induced Acute Lung Injury In Mice

Interleukin-10 Contributes To Therapeutic Effect Of Mesenchymal Stem Cells For Acute Liver Failure Via Signal Transducer And Activator Of Transcription 3 Signaling Pathway

Mesenchymal Stem Cells Attenuate Acute Lung Injury in Mice Partly by Suppressing Alveolar Macrophage Activation in a PGE2-dependent Manner

Mesenchymal Stem Cells Increase Expression of Heme Oxygenase-1 Leading to Anti-Inflammatory Activity in Treatment of Acute Liver Failure

Mesenchymal Stem Cell Repair Acute Hepatocyte Injury Through Inducing Macrophages M2 Polarization Via STAT6

Human Umbilical Cord Mesenchymal Stem Cells Ameliorate Acute Liver Failure by Inhibiting Apoptosis, Inflammation and Pyroptosis

Mesenchymal Stem Cells Alleviate Bacteria-Induced Liver Injury in Mice by Inducing Regulatory Dendritic Cells